http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2698366-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f220ff41ebe4c7f2e7da8ec7e7e9dca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2019-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d597576bc6ffaf44f0ed8b1bc0d8e61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa75fea28a5411ea9cba46fc0286f699 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd43c9b1ec1b3f1853b39bfd51c44f17 |
| publicationDate | 2019-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2698366-C1 |
| titleOfInvention | Method of treating choroidal effusion following an antiglaucomatous surgery |
| abstract | FIELD: medicine.SUBSTANCE: invention relates to medicine, specifically to ophthalmology. For the purpose of treating a choroidal effusion following an antiglaucomatous operation, a corneal paracentesis is performed, through which a viscoelastic is inserted through the cannula into an anterior chamber. Viscoelastic is represented by Viscot in amount of 0.3–0.4 ml to achieve IOP of 28–30 mm Hg, which is determined intraoperatively by means of a contact tonometer. Further, in the projection of the bladder of the choroidal effusion at distance of 4 mm from the limb, conjunctival incision 2.0–3.0 mm long is performed parallel to it. After separation of conjunctiva and tenon coat, sclera vessels are coagulated by ultrasonic coagulator. Further, the blade is incised with a triangular incision of the sclera with base of 1.0–2.0 mm and height of 1.0–1.5 mm, with excision of the scleral fragment and exposure of the choroid and subsequent overlapping of the nodal suture on the conjunctiva.EFFECT: method enables restoring the normal anatomical interrelation of the structures of the anterior eye segment and normalizing intraocular pressure with preserving the effectiveness of antiglaucomatous surgery while reducing the length of hospital stay.1 cl, 3 ex |
| priorityDate | 2019-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.